Tolerability and safety of weekly primaquine against relapse of Plasmodium vivax in Cambodians with glucose-6-phosphate dehydrogenase deficiency

BACKGROUND: Primaquine is used to prevent Plasmodium vivax relapse; however, it is not implemented in many malaria-endemic countries, including Cambodia, for fear of precipitating primaquine-induced acute haemolytic anaemia in patients with glucose-6-phosphate dehydrogenase deficiency (G6PDd). Reluc...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: Kheng, Sim, Muth, Sinoun, Taylor, Walter R. J., Tops, Narann, Kosal, Khem, Sothea, Khon, Souy, Phum, Kim, Saorin, Char, Chuor Meng, Vanna, Chan, Ly, Po, Ringwald, Pascal, Khieu, Virak, Kerleguer, Alexandra, Tor, Pety, Baird, John K., Bjorge, Steven, Menard, Didier, Christophel, Eva
Aineistotyyppi: Online Artikkeli Teksti
Kieli:English
Julkaistu: BioMed Central 2015
Aiheet:
Research Article
Linkit:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4549079/
https://www.ncbi.nlm.nih.gov/pubmed/26303162
http://dx.doi.org/10.1186/s12916-015-0441-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4549079/
https://www.ncbi.nlm.nih.gov/pubmed/26303162
http://dx.doi.org/10.1186/s12916-015-0441-1

Samankaltaisia teoksia